Apoptosis and Nitrative Stress Associated with Phosphodiesterase Inhibitor-Induced Mesenteric Vasculitis in Rats

Abstract

Nitric oxide may play a role in phosphodiesterase (PDE) inhibitor-induced rat mesenteric vasculitis. The present study was conducted to identify cellular sources of iNOS, determine the distribution of nitrotyrosine (NT) residues as a footprint of peroxynitrite (ONOO-) production, and evaluate their association with vascular apoptosis. To dissociate primary events from secondary changes associated with the inflammatory response, rats were given the PDE IV inhibitor CI-1018 orally at 750 mg/kg alone or concurrently with dexamethasone (DEX) intraperitoneally at 1 mg/kg for 4—5 days. Neutrophil (PMN) involvement in apoptosis was investigated in CI-1018 treated rats dosed with rabbit anti-rat PMN serum (APS). iNOS expression, NT residues, and caspase-3 were detected by immuno-histochemistry. Apoptosis was evaluated by TUNEL assay. CI-1018 induced vascular lesions were associated with iNOS expression in endothelial cells and inflammatory infiltrates; NT was evident only in the latter. Caspase-3 and TUNEL-positive staining were prominent only in medial smooth muscle cells (SMC) from CI-1018-treated rats and only when associated with active inflammation. iNOS- and NT-positive inflammatory cells were present in close proximity to SMC with caspase-3 staining. Inflammatory infiltrates were absent in rats given DEX with minimal SMC necrosis and hemorrhage remained. DEX eliminated apoptosis and immunoreactivity associated with caspase-3, iNOS, and NT. APS depletion of PMNs decreased the incidence and severity of vasculitis but failed to abolish completely caspase-3 immunoreactivity. Expression patterns for caspase-3, iNOS, and NT demonstrated that nitrative stress is a prominent feature of PDE inhibitor-induced vasculitis, with a possible role in medial SMC apoptosis. Further, medial SMC apoptosis may not be a primary event, but instead may be secondary to the inflammatory response.

Keywords

Vasculitis phosphodiesterase inhibitor nitric oxide nitrotyrosine apoptosis dexamethasone neutrophils.

References

Albassam A. , Smith GS , Macallum GE (1998). Arteriopathy induced by an adenosine agonist-antihypertensive in monkeys. Toxicol Pathol 26: 375— 380.

Albina JE , Cui S. , Mateo RB , Reichner JS (1993). Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol 150: 5080— 5085.

Brockhaus F. , Brune B. (1998). U937 apoptotic cell death by nitric oxide: Bcl-2 downregulation and caspase activation. Exp Cell Res 238: 33—41.

Dethloff LA , Pegg DG , Metz A. ( 1999). Preclinical toxicity studies of phosphodiesterase IV inhibitor CI-1018 in rats. Toxicol Sci 48: 1502a.

Fehsel K. , Kroncke KD , Meyer KL , Huber H. , Wahn V. , Kolb BV ( 1995). Nitric oxide induces apoptosis in mouse thymocytes. J Immunol 155: 2858— 2865.

Forrester K. , Ambs S. , Lupold SE , Kapust RB , Spillare EA , Weinberg WC , Felley-Bosco E. , Wang XW , Geller DA , Tzeng E. , Billiar TR , Harris CC (1996). Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc Natl Acad Sci USA 93: 2442—2447.

Fukuo K. , Hata S. , Suhara T. , Nakahashi T. , Shinto Y. , Tsujimoto Y. , Morimoto S. , Ogihara T. (1996). Nitric oxide induces upregulation of Fas and apoptosis in vascular smooth muscle. Hypertension 27: 823—826.

Genaro AM , Hortelano S. , Alvarez A. , Martinez C. , Bosca L. (1995). Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J Clin Invest 95: 1884—1890.

Green DR , Reed JC ( 1998). Mitochondria and apoptosis. Science 281: 1309— 1312.

10.

Geller DA , Nussler AK , Di Silvio M. , Lowenstein CJ , Shapiro RA , Wang SC , Simmons RL , Billiar TR (1993). Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci USA 90: 522—526.

11.

Giembycz MA (2001). Cilomilast: a second generation phosphodiesterase 4 inhibitor for asthma and chronic obstructive pulmonary disease. Expert Opin Investig Drugs 10: 1361—1379.

12.

Giembycz MA , Raeburn D. (1991). Putative substrates for cyclic nucleotide-dependent protein kinases and the control of airway smooth muscle tone. J Auton Pharmacol 11: 365—398.

13.

Gilbert RS , Herschman HR (1993). “Macrophage” nitric oxide synthase is a glucocorticoid-inhibitable primary response gene in 3T3 cells. J Cell Physiol 157: 128—132.

14.

Hayashi S. , Morishita R. , Matsushita H. , Nakagami H. , Taniyama Y. , Nakamura T. , Aoki M. , Yamamoto K. , Higaki J. , Ogihara T. (2000). Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21 Hypertension 35: 237—243.

15.

Iwashina M. , Shichiri M. , Marumo F. , Hirata Y. (1998). Transfection of inducible nitric oxide synthase gene causes apoptosis in vascular smooth muscle cells . Circulation 98: 1212—1218.

16.

Jiang X. , Li J. , Paskind M. , Epstein PM (1996). Inhibition of calmodulindependent phosphodiesterase induces apoptosis in human leukemic cells. Proc Natl Acad Sci USA 93: 11236—11241.

17.

Joseph EC , Mesfin G. , Kerns WD (1997). Pathogenesis of arterial lesions caused by vasoactive compounds in laboratory animals. In: Comprehensive Toxicology, Vol 6, Cardiovascular Toxicology, Bishop SP , Kerns WD (eds). Pergamon, New York, pp 279—307.

18.

Joseph EC , Rees JA , Dayan AD (1996). Mesenteric arteriopathy in the rat induced by phosphodiesterase III inhibitors: an investigation of morphological, ultrastructural, and hemodynamic changes. Toxicol Pathol 24: 436—450.

19.

Kaneto H. , Fujii J. , Seo HG , Suzuki K. , Matsuoka T. , Nakamura M. , Tatsumi H. , Yamasaki Y. , Kamada T. , Taniguchi N. (1995). Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells. Diabetes 44: 733—738.

20.

Kolb H. , Kolb-Bachofen V. (1992). Nitric oxide: a pathogenetic factor in autoimmunity . Immunol Today 13:157—160.

21.

Larson JL , Pino MV , Geiger LE , Simeone CR (1996). The toxicity of repeated exposures to rolipram, a type IV phosphodiesterase inhibitor, in rats. Pharmacol Toxicol 78: 44—49.

22.

Mannick JB , Asano K. , Izumi K. , Kieff E. , Stamler JS (1994). Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 79:1137—1146.

23.

MentzF. , Mossalayi MD , OuaazF. , Baudet S. , Issaly F. , Ktorza S. , Semichon M. , Binet JL , Merle-Beral H. (1996). Theophylline synergizes with chlorambucil in inducing apoptosis of B-chronic lymphocytic leukemia cells. Blood 88: 2172—2182.

24.

Messmer UK , Ankarcrona M. , Nicotera P. , Brune B (1994). p53 expression in nitric oxide-induced apoptosis. FEBS Lett 355: 23—26.

25.

Moncada S. , Palmer RMJ , Higgs EA (1991). Nitric oxide: physiology, pathology, and pharmacology . Pharmacol Rev 43: 109—142.

26.

Mulligan MS , Hovel JM , Marletta MA , Ward PA (1991). Tissue injury caused by deposition of immune complexes is L-arginine dependent . Proc Natl Acad Sci 88: 6338—6342.

27.

Nathan C. , Xie Q-W. (1994). Nitric oxide syntheses, roles, tolls, and controls . Cell 78: 915—918.

28.

Pfeilschifter J. , Huwiler A. (1996). Nitric oxide stimulates stress-activated protein kinases in glomerular endothelial and mesangial cells . FEBS Lett 396: 67—70.

29.

Pollman MJ , Yamada T. , Horiuchi M. , Gibbons GH (1996). Vasoactive substances regulate vascular smooth muscle cell apoptosis: countervailing influences of nitric oxide and angiotensin II. Circ Res 79: 748—756.

30.

Radomski MW , Palmer RM , Moncada S. (1990). Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci 87: 10043—10047.

31.

Robertson DG , Reily DR , Albassam M. , Dethloff LA (2001). Metabonomic assessment of vasculitis on rats. Cardiovasc Toxicol 1: 7—9.

32.

Slim RM , Robertson DG , Albassam M. , Reily MD , Robosky L. , Dethloff LA (2002). Effect of dexamethasone on the metabonomics profile associated with phosphodiesterase inhibitor-induced vascular lesions in rats . Toxicol Appl Pharmacol 183: 108—109.

33.

Szabo C. , Zingarelli B. , O'Connor M. , Salzman AL (1996). DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci USA 93: 1753—1758.

34.

Teixeira MM , Gristwood RW , Cooper N. , Hellewell PG (1997). Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future? Trends Pharmacol Sci 18: 164—171.

35.

Thornberry NA , Lazebnik Y. (1998). Caspases: enemies within . Science 281: 1312—1316.

36.

Xie K. , Huang S. , Dong Z. , Juang SH , Gutman M. , Xie QW , Nathan C. , Fidler IJ (1995). Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J Exp Med 181: 1333—1343.

37.

Zhang J. , Herman EH , Knapton A. , Chadwick DP , Whitehurst VE , Koerner JE , Papoian T. , Ferrans VJ , Sistare FD (2002). SK&F 95654-Induced Acute Cardiovascular Toxicity in Sprague-Dawley Rats-Histopathologic, Electron Microscopic, and Immunohistochemical Studies. Toxicol Pathol 30: 28—40.